FDA Authorizes Second COVID Vaccine Booster Shots For Adults Age 50 And Older
The US Food and Drug Administration has expanded the emergency use authorization of the Pfizer and Moderna Covid-19 vaccines to allow adults age 50 and older.
Watch CBS News
The US Food and Drug Administration has expanded the emergency use authorization of the Pfizer and Moderna Covid-19 vaccines to allow adults age 50 and older.
Moderna's COVID-19 vaccine works in babies, toddlers and preschoolers the company announced Wednesday -- and if regulators agree it could mean a chance to finally start vaccinating the littlest kids by summer.
Full approval means the FDA has completed the same rigorous, time-consuming review for Moderna's shot as dozens of other long-established vaccines.
Moderna said it expects to enroll about 600 people in the study, which will take place at up to 24 sites in the U.S.
There was a fire at Moderna's facility in Norwood Wednesday morning.
Moderna is planning to have a combination COVID and flu vaccine ready for next year.
Moderna announced Monday that preliminary data suggests its half-dose booster shot increased antibody levels against Omicron compared with the levels seen when a fully vaccinated person does not receive a booster.
Moderna said it has been able to advance additional boosters to clinical testing in 60-90 days.
The FDA on Friday authorized Moderna and Pfizer's COVID vaccine booster shots for all adults 18 and older.
Massachusetts is opening up COVID booster shots to any fully vaccinated resident age 18 or older, effective immediately.
Moderna said it is dealing with production and shipment issues that will push some of its deliveries back to 2022.
The FDA is reportedly reviewing more international data before making a decision on whether to greenlight the vaccine in kids ages 12 to 17.
The FDA is delaying their decision on Moderna's COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation.
Moderna says its COVID-19 vaccine for children ages 6 to 11 has a "strong immune response" one month after the second dose.
Vaccine advisers to the US Centers for Disease Control and Prevention voted on Thursday to recommend booster doses of both Moderna's and Johnson & Johnson Covid-19 vaccines.
The Food and Drug Administration authorized Moderna and Johnson and Johnson booster shots Wednesday, the next step in making them a reality. The FDA also said that mixing and matching vaccines is safe.
The Food and Drug Administration is going to let you mix and match Covid-19 vaccine booster shots.
An FDA panel voted "yes" on recommending a third dose of the Moderna vaccine. Dr. Mallika Marshall explains what comes next in the process.
U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.
On the same day an FDA advisory committee recommended Moderna booster shots for vulnerable populations, a new clinic opened in Lowell.
Pfizer's vaccine provided 88% protection against hospitalization, and Moderna's was 93% effective.
Cambridge-based Moderna is working on a booster shot that also protects against the flu.
Fauci said that unlike Pfizer's vaccine booster, there is insufficient data right now on the safety and efficacy of Moderna's booster dose.
A new study is out comparing the COVID vaccine from Cambridge-based biotech company Moderna to the one developed by Pfizer.
Days after Pfizer received FDA backing for its COVID vaccine, Moderna has submitted an application for full approval of its own two-dose shot regimen.
